Clinical trial
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
NCT00184522 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2002
- Completion date
- December 31, 2004
- Enrollment
- 82 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.